Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells

Abstract Background Focal adhesion kinase (FAK) is a cytoplasmatic protein tyrosine kinase that associates with both integrins and growth factor receptors toward the adhesion, migration and invasion of cancer cells. The G-protein coupled estrogen receptor (GPER) has been involved in the stimulatory...

Full description

Bibliographic Details
Main Authors: Damiano Cosimo Rigiracciolo, Maria Francesca Santolla, Rosamaria Lappano, Adele Vivacqua, Francesca Cirillo, Giulia Raffaella Galli, Marianna Talia, Lucia Muglia, Michele Pellegrino, Nijiro Nohata, Maria Teresa Di Martino, Marcello Maggiolini
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-019-1056-8
_version_ 1828532727366811648
author Damiano Cosimo Rigiracciolo
Maria Francesca Santolla
Rosamaria Lappano
Adele Vivacqua
Francesca Cirillo
Giulia Raffaella Galli
Marianna Talia
Lucia Muglia
Michele Pellegrino
Nijiro Nohata
Maria Teresa Di Martino
Marcello Maggiolini
author_facet Damiano Cosimo Rigiracciolo
Maria Francesca Santolla
Rosamaria Lappano
Adele Vivacqua
Francesca Cirillo
Giulia Raffaella Galli
Marianna Talia
Lucia Muglia
Michele Pellegrino
Nijiro Nohata
Maria Teresa Di Martino
Marcello Maggiolini
author_sort Damiano Cosimo Rigiracciolo
collection DOAJ
description Abstract Background Focal adhesion kinase (FAK) is a cytoplasmatic protein tyrosine kinase that associates with both integrins and growth factor receptors toward the adhesion, migration and invasion of cancer cells. The G-protein coupled estrogen receptor (GPER) has been involved in the stimulatory action of estrogens in breast tumor. In this study, we have investigated the engagement of FAK by GPER signaling in triple negative breast cancer (TNBC) cells. Methods Publicly available large-scale database and patient data sets derived from “The Cancer Genome Atlas” (TCGA; www.cbioportal.org) were used to assess FAK expression in TNBC, non-TNBC tumors and normal breast tissues. MDA-MB 231 and SUM159 TNBC cells were used as model system. The levels of phosphorylated FAK, other transduction mediators and target genes were detected by western blotting analysis. Focal adhesion assay was carried out in order to determine the focal adhesion points and the formation of focal adhesions (FAs). Luciferase assays were performed to evaluate the promoters activity of c-FOS, EGR1 and CTGF upon GPER activation. The mRNA expression of the aforementioned genes was measured by real time-PCR. Boyden chamber and wound healing assays were used in order to evaluate cell migration. The statistical analysis was performed by ANOVA. Results We first determined by bioinformatic analysis that the mRNA expression levels of the gene encoding FAK, namely PTK2, is higher in TNBC respect to non-TNBC and normal breast tissues. Next, we found that estrogenic GPER signaling triggers Y397 FAK phosphorylation as well as the increase of focal adhesion points (FAs) in TNBC cells. Besides, we ascertained that GPER and FAK activation are involved in the STAT3 nuclear accumulation and gene expression changes. As biological counterpart, we show that FAK inhibition prevents the migration of TNBC cells upon GPER activation. Conclusions The present data provide novel insights regarding the action of FAK in TNBC. Moreover, on the basis of our findings estrogenic GPER signaling may be considered among the transduction mechanisms engaging FAK toward breast cancer progression.
first_indexed 2024-12-11T22:57:19Z
format Article
id doaj.art-ae60ac6c3e34402aae113891fea6ad26
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-11T22:57:19Z
publishDate 2019-02-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-ae60ac6c3e34402aae113891fea6ad262022-12-22T00:47:12ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662019-02-0138111610.1186/s13046-019-1056-8Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cellsDamiano Cosimo Rigiracciolo0Maria Francesca Santolla1Rosamaria Lappano2Adele Vivacqua3Francesca Cirillo4Giulia Raffaella Galli5Marianna Talia6Lucia Muglia7Michele Pellegrino8Nijiro Nohata9Maria Teresa Di Martino10Marcello Maggiolini11Department of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaMSD K.KDepartment of Experimental and Clinical Medicine, Magna Graecia UniversityDepartment of Pharmacy, Health and Nutritional Sciences, University of CalabriaAbstract Background Focal adhesion kinase (FAK) is a cytoplasmatic protein tyrosine kinase that associates with both integrins and growth factor receptors toward the adhesion, migration and invasion of cancer cells. The G-protein coupled estrogen receptor (GPER) has been involved in the stimulatory action of estrogens in breast tumor. In this study, we have investigated the engagement of FAK by GPER signaling in triple negative breast cancer (TNBC) cells. Methods Publicly available large-scale database and patient data sets derived from “The Cancer Genome Atlas” (TCGA; www.cbioportal.org) were used to assess FAK expression in TNBC, non-TNBC tumors and normal breast tissues. MDA-MB 231 and SUM159 TNBC cells were used as model system. The levels of phosphorylated FAK, other transduction mediators and target genes were detected by western blotting analysis. Focal adhesion assay was carried out in order to determine the focal adhesion points and the formation of focal adhesions (FAs). Luciferase assays were performed to evaluate the promoters activity of c-FOS, EGR1 and CTGF upon GPER activation. The mRNA expression of the aforementioned genes was measured by real time-PCR. Boyden chamber and wound healing assays were used in order to evaluate cell migration. The statistical analysis was performed by ANOVA. Results We first determined by bioinformatic analysis that the mRNA expression levels of the gene encoding FAK, namely PTK2, is higher in TNBC respect to non-TNBC and normal breast tissues. Next, we found that estrogenic GPER signaling triggers Y397 FAK phosphorylation as well as the increase of focal adhesion points (FAs) in TNBC cells. Besides, we ascertained that GPER and FAK activation are involved in the STAT3 nuclear accumulation and gene expression changes. As biological counterpart, we show that FAK inhibition prevents the migration of TNBC cells upon GPER activation. Conclusions The present data provide novel insights regarding the action of FAK in TNBC. Moreover, on the basis of our findings estrogenic GPER signaling may be considered among the transduction mechanisms engaging FAK toward breast cancer progression.http://link.springer.com/article/10.1186/s13046-019-1056-8TNBCMDA-MB 231SUM159GPERG-15FAK
spellingShingle Damiano Cosimo Rigiracciolo
Maria Francesca Santolla
Rosamaria Lappano
Adele Vivacqua
Francesca Cirillo
Giulia Raffaella Galli
Marianna Talia
Lucia Muglia
Michele Pellegrino
Nijiro Nohata
Maria Teresa Di Martino
Marcello Maggiolini
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
Journal of Experimental & Clinical Cancer Research
TNBC
MDA-MB 231
SUM159
GPER
G-15
FAK
title Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
title_full Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
title_fullStr Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
title_full_unstemmed Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
title_short Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
title_sort focal adhesion kinase fak activation by estrogens involves gper in triple negative breast cancer cells
topic TNBC
MDA-MB 231
SUM159
GPER
G-15
FAK
url http://link.springer.com/article/10.1186/s13046-019-1056-8
work_keys_str_mv AT damianocosimorigiracciolo focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT mariafrancescasantolla focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT rosamarialappano focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT adelevivacqua focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT francescacirillo focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT giuliaraffaellagalli focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT mariannatalia focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT luciamuglia focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT michelepellegrino focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT nijironohata focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT mariateresadimartino focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells
AT marcellomaggiolini focaladhesionkinasefakactivationbyestrogensinvolvesgperintriplenegativebreastcancercells